Drug Combinatorial Therapies for the Treatment of KRAS Mutated Lung Cancers

He, H; Xu, C; Cheng, Z; Qian, XY; Zheng, L

He, H; Zheng, L (reprint author), Xian Med Univ, Sch Pharm, Xian, Shaanxi, Peoples R China.

CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2019; 19 (23): 2128

Abstract

KRAS is the most common oncogene to be mutated in lung cancer, and therapeutics directly targeting KRAS have proven to be challenging. The mutations o......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索